Consilient Health
Private Company
Total funding raised: $30M
Overview
Consilient Health operates as a commercial-stage pharmaceutical company, acting as a strategic commercialization partner for biotech and pharma companies seeking market access in the UK and Europe. Its business model is exclusively commercial, leveraging expertise in regulatory affairs, market access, supply chain, and marketing to launch and grow prescription products. As a profitable, private entity with a strong financial foundation, it prioritizes long-term partnerships and sustainable business practices while maintaining a portfolio of established products in specialized therapeutic areas.
Technology Platform
Integrated commercialisation platform for the UK and Europe, encompassing regulatory affairs, market access, supply chain, medical affairs, marketing, and sales expertise.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Consilient Health competes with other specialty commercialisation partners, large generic pharmaceutical companies with European divisions, and the internal commercial teams of larger pharma. Its differentiation lies in its mid-sized agility, deep regional expertise in niche areas, and full-service, partnership-focused model.